These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 5457933)

  • 1. Antigenicity of cells derived from mouse prostate cells after malignant transformation in vitro by carcinogenic hydrocarbons.
    Mondal S; Iype PT; Griesbach LM; Heidelberger C
    Cancer Res; 1970 Jun; 30(6):1593-7. PubMed ID: 5457933
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative and qualitative studies of chemical transformation of cloned C3H mouse embryo cells sensitive to postconfluence inhibition of cell division.
    Reznikoff CA; Bertram JS; Brankow DW; Heidelberger C
    Cancer Res; 1973 Dec; 33(12):3239-49. PubMed ID: 4796800
    [No Abstract]   [Full Text] [Related]  

  • 3. The antigenicity and immunogenicity of cell-free extracts of chemically induced murine sarcomas.
    Pilch YH
    Cancer Res; 1968 Dec; 28(12):2502-11. PubMed ID: 4302533
    [No Abstract]   [Full Text] [Related]  

  • 4. Generation of tumor-specific transplantation antigens by UV radiation can occur independently of neoplastic transformation.
    Hostetler LW; Ananthaswamy HN; Kripke ML
    J Immunol; 1986 Oct; 137(8):2721-5. PubMed ID: 3760572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of different cancer treatment methods on immunity to an antigenic transplantable murine fibrosarcoma (Meth A).
    Khafagy M; Wanebo HJ; Alfieri A; Hahn EW
    AJR Am J Roentgenol; 1977 Jun; 128(6):1027-9. PubMed ID: 414534
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunospecific regression of methylcholanthrene fibrosarcoma with the use of neuraminidase.
    Simmons RL; Rios A; Lundgren G; Ray PK; McKhann CF; Haywood GR
    Surgery; 1971 Jul; 70(1):38-46. PubMed ID: 5092115
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantitation of chemically induced neoplastic transformation of BALB-3T3 cloned cell lines.
    DiPaolo JA; Takano K; Popescu NC
    Cancer Res; 1972 Dec; 32(12):2686-95. PubMed ID: 4674680
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunogenic strength of sarcomas induced by methylcholanthrene in millipore filter diffusion chambers.
    Parmiani G; Carbone G; Lembo R
    Cancer Res; 1973 Apr; 33(4):750-4. PubMed ID: 4696474
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro malignant transformation by methylcholanthrene of the progeny of single cells derived from C3H mouse prostate.
    Mondal S; Heidelberger C
    Proc Natl Acad Sci U S A; 1970 Jan; 65(1):219-25. PubMed ID: 5263752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current topics on tumor immunology].
    Tachibana T
    Gan No Rinsho; 1983 Oct; 29(13):1492-8. PubMed ID: 6608013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific desensitization of resistance against a syngeneic methylcholanthrene-induced sarcoma in C3Hf mice.
    Vaage J
    Cancer Res; 1972 Feb; 32(2):193-9. PubMed ID: 5058179
    [No Abstract]   [Full Text] [Related]  

  • 12. Syngeneic monoclonal antibodies to a methylcholanthrene-induced mouse sarcoma.
    Lennox E; Cohn J; Lowe T
    Transplant Proc; 1980 Mar; 12(1):95-8. PubMed ID: 7368297
    [No Abstract]   [Full Text] [Related]  

  • 13. In vivo and in vitro studies of the influence of the immune status of C3Hf-Bu mice on the effectiveness of local irradiation of a methylcholanthrene-induced fibrosarcoma.
    Jurin M; Suit HD
    Cancer Res; 1972 Oct; 32(10):2201-11. PubMed ID: 5080765
    [No Abstract]   [Full Text] [Related]  

  • 14. Castration effects on tumor specific immunity.
    Brannen GE; Gomolka DM; Wettlaufer JN; Modarelli RO
    Invest Urol; 1977 Jul; 15(1):28-38. PubMed ID: 873734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of lymphocytes and serum of C3Hf-Bu mice during the growth of methylcholanthrene-induced tumor and its regression following local irradiation.
    Jurin M; Suit HD
    Cancer Res; 1974 Apr; 34(4):672-8. PubMed ID: 4814987
    [No Abstract]   [Full Text] [Related]  

  • 16. Simultaneous decrease of tumor-specific antigenicity and "hybrid effect" in a murine methylcholanthrene-induced sarcoma.
    Oth D; Donner M; Burg C
    Transplantation; 1969 Nov; 8(5):742-5. PubMed ID: 5403331
    [No Abstract]   [Full Text] [Related]  

  • 17. MCG101-AA, a new ascites tumour in C57 mice. 1. Induction procedures and some cytological and physicochemical characteristics.
    Hagmar B
    Acta Pathol Microbiol Scand A; 1974 May; 82(3):358-68. PubMed ID: 4853307
    [No Abstract]   [Full Text] [Related]  

  • 18. Passive transfer of tumor-specific resistance to methylcholanthrene-induced sarcomas in rats.
    Ishikawa Y; Fukushima M; Sato T; Komaba M; Yagihashi H
    Tohoku J Exp Med; 1971 Feb; 103(2):195-201. PubMed ID: 5580594
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumor-secific immunity to chemically induced tumors. Evidence for immunologic specificity and shared antigenicity in lymphocyte responses to soluble tumor antigens.
    Frbes JT; Nakaw Y; Smith RT
    J Exp Med; 1975 May; 141(5):1181-200. PubMed ID: 47896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant transformation of cells derived from mouse prostate by epoxides and other derivatives of polycyclic hydrocarbons.
    Marquardt H; Kuroki T; Huberman E; Selkirk JK; Heidelberger C; Grover PL; Sims P
    Cancer Res; 1972 Apr; 32(4):716-20. PubMed ID: 5014782
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.